CORC

在结果中检索

CORC

浏览/检索结果: 共32条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study 期刊论文
GENES CHROMOSOMES & CANCER, 2022
作者:  Wang, Wenxian;  Gu, Xiaodong;  Si, Jinfei;  Pu, Xingxiang;  Wang, Liping
收藏  |  浏览/下载：31/0  |  提交时间：2022/05/16
Transformer-Based Generative Model Accelerating the Development of Novel BRAF Inhibitors 期刊论文
ACS OMEGA, 2021, 卷号: 6, 期号: 49, 页码: 33864-33873
作者:  Yang, Lijuan;  Yang, Guanghui;  Bing, Zhitong;  Tian, Yuan;  Niu, Yuzhen
收藏  |  浏览/下载：16/0  |  提交时间：2022/04/11
Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 11
作者:  Tao, Zhonghua;  Liu, Jianxia;  Li, Ting;  Xu, Hong;  Chen, Kai
收藏  |  浏览/下载：33/0  |  提交时间：2022/01/10
MAPK Inhibitors Enhance HDAC Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Cells Harboring BRAF(V600E) : An In Vitro 期刊论文
MOLECULAR THERAPY-ONCOLYTICS, 2019, 卷号: 12
作者:  Cheng, Lingxiao;  Cheng, Lin;  Liu, Min;  Chen, Libo;  Fu, Hao
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors (vol 9, 679, 2018) 期刊论文
CELL DEATH & DISEASE, 2019, 卷号: 10
作者:  Lei, Fu Xi;  Jin, Lei;  Liu, Xiao Ying;  Lai, Fritz;  Yan, Xu Guang
收藏  |  浏览/下载：9/0  |  提交时间：2019/11/19
Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma 期刊论文
ACTA PHARMACOLOGICA SINICA, 2019, 卷号: Vol.40 No.2, 页码: 268-278
作者:  Gao, Ming-zhao;  Wang, Hong-bin;  Chen, Xiang-ling;  Cao, Wen-ting;  Fu, Li
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/13
Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors 期刊论文
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 卷号: 20, 期号: 17
作者:  Aasen, Synnove Nymark;  Parajuli, Himalaya;  Tuyen Hoang;  Feng, Zichao;  Stokke, Krister
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11
Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma 期刊论文
Acta Pharmacologica Sinica, 2019, 卷号: 第40卷 第2期, 页码: 268-278
作者:  Ming-zhao Gao;  Hong-bin Wang;  Xiang-ling Chen;  Wen-ting Cao;  Li Fu
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/13
Resistance mechanism of the oncogenic beta 3-alpha C deletion mutation in BRAF kinase to dabrafenib and vemurafenib revealed by molecular dynamics simulations and binding free energy calculations 期刊论文
CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 卷号: 93, 期号: 2, 页码: 177-187
作者:  
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11
aberrantmodulationofribosomalproteins6phosphorylationconfersacquiredresistancetomapkpathwayinhibitorsinbrafmutantmelanoma 期刊论文
中国药理学报英文版, 2019, 卷号: 040, 期号: 002, 页码: 268
作者:  
收藏  |  浏览/下载：6/0  |  提交时间：2020/07/01

©版权所有 ©2017 CSpace - Powered by CSpace